凝块组成和缺血性中风病因:当代叙事审查
Jacob Kosyakovsky1, Christina P Rossitto1, Joseph P Antonios2
1Department of Neurosurgery, Mass General Brigham, Harvard Medical School, Boston, MA 02115, USA.
Journal of clinical medicine
|September 13, 2025
概括
在急性缺血性中风 (AIS) 中分析血块组成有助于确定中风的原因. 先进的多原子技术为更好的二次中风预防策略提供了对凝块病理学的新见解.
科学领域:
- 神经学 神经学
- 病理学 病理学 病理学
- 生物化学 生物化学
背景情况:
- 急性缺血性中风 (AIS) 是全球死亡和残疾的主要原因.
- 了解中风病因对于有效的二次预防至关重要.
- 机械血栓切除术 (MT) 提供取回的凝块进行分析,推进凝块组成研究.
研究的目的:
- 审查当前对中风病因及其与凝块组成的关系的理解.
- 探索包括组织学和多组学在内的凝块分析如何为中风病因学预测提供信息.
- 突出下一代测序技术在AIS诊断和管理中的潜力.
主要方法:
- 对AIS中的凝块组成现有文献的审查.
- 在MT过程中检索到的血块的组织学和分子特征的分析.
- 从凝块分析中探索蛋白质组和转录组数据.
主要成果:
- 大动脉动脉样硬化 (LAA) 和心血管血栓 (CE) 血栓之间存在差异,但临床预测仍然具有挑战性.
- 多原子测序为详细了解凝块病理学提供了潜在的可能性.
- 组织学和分子分析为中风病因提供了洞察力.
结论:
- 凝块组成分析是一个不断发展的领域,对理解AIS有很大的潜力.
- 下一代多核技术可以为临床诊断和中风管理提供所需的细粒度.
- 结合多核数据的进一步研究可能会改善二次中风的预防.
相关概念视频
Clot Retraction and Fibrinolysis
8.5K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
8.5K
Ischemic Heart Disease: Overview
3.0K
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
3.0K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
1.7K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.7K
Venous Thrombosis I: Introduction
375
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
375
Extrinsic and Intrinsic Pathways of Hemostasis
12.1K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
12.1K
Coagulation
9.7K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
9.7K


